-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on Hoth Therapeutics, Maintains $5 Price Target

Benzinga·11/17/2025 13:11:56
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains Hoth Therapeutics (NASDAQ:HOTH) with a Buy and maintains $5 price target.